Home / MissionIR Articles

MissionIR Articles

  • Rosetta Genomics (ROSG) Presents at Rodman & Renshaw Conference

    Rosetta Genomics Ltd. (NASDAQ: ROSG) develops and commercializes a broad range of microRNA-based and other high-value molecular diagnostics. The company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of…

  • Rock Creek Pharmaceuticals (RCPI) Presents at Rodman & Renshaw Conference

    Rock Creek Pharmaceuticals, Inc. (NASDAQ: RCPI) is a clinical-stage drug development company focused on the discovery, development and commercialization of new drugs, formulations and compounds that provide therapies for chronic inflammatory disease and neurologic disorders.…

  • Rexahn Pharmaceuticals (RNN) Presents at Rodman & Renshaw Conference

    Rexahn Pharmaceuticals, Inc. (NYSE: RNN) is a clinical-stage biopharmaceutical company dedicated to the development of novel, best-in-class therapeutics for the treatment of cancer. The company’s product candidates work by targeting and neutralizing specific proteins believed…

  • RestorGenex (RESX) Presents at Rodman & Renshaw Conference

    RestorGenex Corporation (OTCQB: RESX) is a specialty biopharmaceutical company focused on the development of a portfolio of first-in-class therapeutic products to treat diseases across the oncologic, ophthalmologic and dermatologic space. The company’s lead product is…

  • RegeneRx Biopharmaceuticals (RGRX) Presents at Rodman & Renshaw Conference

    RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) is a biopharmaceutical company focused on the development of a novel therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair and regeneration. The company currently has three drug…

  • Reed’s (REED) Presents at Rodman & Renshaw Conference

    Reed’s, Inc. (NYSE: REED) produces the top-selling natural sodas in the natural foods industry and is sold in more than 15,000 natural and mainstream supermarkets nationwide. Additionally, the company’s products are sold through specialty gourmet…

  • RedHill Biopharma (RDHL) Presents at Rodman & Renshaw Conference

    RedHill Biopharma Ltd. (NASDAQ: RDHL) is an emerging Israeli biopharmaceutical company primarily focused on the development of late clinical-stage small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, including gastrointestinal cancers. The company’s…

  • RealNetworks (RNWK) Presents at Rodman & Renshaw Conference

    RealNetworks, Inc. (NASDAQ: RNWK) creates innovative applications and services that make it easy for consumers to connect with and enjoy digital media on the devices and platforms they choose to use. The company invented the…

  • Rare Element Resources (REE) Presents at Rodman & Renshaw Conference

    Rare Element Resources Ltd. (NYSE: REE) is a strategic materials company focused on delivering rare earth products for technology and defense applications by advancing its Bear Lodge project in northeast Wyoming. Bear Lodge is a…

  • Radcom (RDCM) Presents at Rodman & Renshaw Conference

    RADCOM Ltd. (NASDAQ: RDCM) provides innovative service assurance and customer experience management solutions for leading telecom operators and communications service providers. The company specializes in solutions for next-generation mobile and fixed networks – including LTE,…

  • Quantum Materials (QTMM) Presents at Rodman & Renshaw Conference

    Quantum Materials Corp. (OTCBB: QTMM) develops and manufactures Quantum Dots and nanomaterials for use in display, lighting, medical and solar energy through its patented continuous-flow production process. Quantum Materials’ products are the foundation for technologically…

  • Pure Bioscience (PURE) Presents at Rodman & Renshaw Conference

    Pure Bioscience, Inc. (OTCQB: PURE) is focused on developing and commercializing its proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. Its technology platform is based on…

  • Pulmatrix (PULM) Presents at Rodman & Renshaw Conference

    Pulmatrix, Inc. (NASDAQ: PULM) is developing innovative inhaled therapies to address serious pulmonary disease using its clinically validated, proprietary iSPERSE technology. Leveraging the unique capabilities of iSPERSE to dramatically advance inhalation technology, the company means…

  • Protalex (PRTX) Presents at Rodman & Renshaw Conference

    Protalex, Inc. (OTCBB: PRTX) is a biotechnology company developing a new class of drugs with the potential to revolutionize the treatment of autoimmune and inflammatory diseases, including Rheumatoid Arthritis (RA) and Immune Thrombocytopenia (ITP). Protalex’s…

  • Prima BioMed (PBMD) Presents at Rodman & Renshaw Conference

    Prima BioMed Ltd. (NASDAQ: PBMD) is a globally active biotechnology company that is striving to become a leader in the development of immunotherapeutic products for the treatment of cancer. Prima BioMed is dedicated to leveraging…

  • Pretium Resources (PVG) Presents at Rodman & Renshaw Conference

    Pretium Resources, Inc. (NYSE: PVG) is advancing the high-grade gold Brucejack Project to production. The company is creating value through gold at its 100%-owned, advanced-stage Brucejack Project, which is located 65 kilometers north of the…

  • PolyMet Mining (PLM) Presents at Rodman & Renshaw Conference

    PolyMet Mining Corp. (NYSE: PLM) is a mine development company focused on permitting, building and operating the NorthMet copper-nickel-precious metals project through its wholly owned subsidiary, Poly Met Mining, Inc., a Minnesota corporation. Through long-term…

  • Pointer Telocation (PNTR) Presents at Rodman & Renshaw Conference

    Pointer Telocation Ltd. (NASDAQ: PNTR) is a leading provider of cutting-edge products and technology, and Software as a Service (SaaS) to the fleet, automotive, insurance, cargo and public-safety industries. Pointer Telocation has a growing client…

  • Plug Power (PLUG) Presents at Rodman & Renshaw Conference

    Plug Power, Inc. (NASDAQ: PLUG)aims to revolutionize the fuel cell industry with cost-effective solutions that increase productivity, lower operating costs and reduce carbon footprint. Its signature solution, GenKey, provides an all-inclusive package for customers, incorporating…

  • Pieris Pharmaceuticals (PIRS) Presents at Rodman & Renshaw Conference

    Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is a clinical-stage biotechnology company applying its proprietary Anticalin technology to create differentiated drugs that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a…

  • Pershing Gold (PGLC) Presents at Rodman & Renshaw Conference

    Pershing Gold Corporation (OTCQB: PGLC) is an emerging Nevada gold producer uniquely positioned to create shareholder value by fast-track reopening of the Relief Canyon Mine. The company’s strategy to create shareholder value has four elements:…

  • Perseon (PRSN) Presents at Rodman & Renshaw Conference

    Perseon Corporation (NASDAQ: PRSN)is singularly focused on fighting one of humanity’s worst diseases, cancer, and on helping physicians and their patients fight cancer with technology. The company is dedicated to developing innovative technologies to fight…

  • Perma-Fix Environmental Services (PESI) Presents at Rodman & Renshaw Conference

    Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) is a nuclear services company and provider of nuclear and mixed waste management services. The company’s nuclear waste services include management and treatment of radioactive and mixed waste for…

  • PCM (PCMI) Presents at Rodman & Renshaw Conference

    Since 1987, PCM, Inc. (NASDAQ: PCMI) has provided IT products, services and solutions to businesses, government agencies, educational, institutions and healthcare facilities. The company provides access to more than 300,000 IT products like tablets, slate,…

  • EDAP TMS S.A (EDAP) Presents at Rodman & Renshaw Conference

    EDAP TMS S.A. (NASDAQ: EDAP) is a global leader in therapeutic ultrasound that has been present in the market for more than 35 years. The company develops, manufactures, promotes and distributes minimally-invasive medical devices for…

  • PAR Technology (PAR) Presents at Rodman & Renshaw Conference

    PAR Technology Corp. (NYSE: PAR)offers technology solutions for the full spectrum of restaurant operations, from large chain and independent table service restaurants to international quick service chains. PAR’s Hospitality business also markets hotel management systems…

  • OXIS International (OXIS) Presents at Rodman & Renshaw Conference

    OXIS International, Inc. (OTC: OXIS)develops innovative drugs focused on the treatment of cancer and other unmet medical needs.  OXIS’ lead drug candidate, DT2219ARL, is a novel bispecific scFv recombinant fusion protein-drug that simultaneously targets cancer…

  • OvaScience (OVAS) Presents at Rodman & Renshaw Conference

    OvaScience, Inc. (NASDAQ: OVAS) is a global fertility company; each OvaScience treatment is based on the company’s proprietary technology platform that leverages the breakthrough discovery of egg precursor (EggPCSM) cells – immature egg cells found…

  • OvaScience (OVAS) Presents at Rodman & Renshaw Conference

    OvaScience, Inc. (NASDAQ: OVAS) is a global life sciences company dedicated to improving fertility for women around the world. OvaScience is discovering, developing and commercializing new fertility treatments because it believes women deserve more options.…

  • Orient Paper (ONP) Presents at Rodman & Renshaw Conference

    Orient Paper, Inc. (NYSE: ONP) is a leading paper manufacturer in North China. Using recycled paper as its primary raw material (with the exception of its digital photo paper and tissue paper products), Orient Paper produces…

  • Oramed Pharmaceuticals (ORMP) Presents at Rodman & Renshaw Conference

    Oramed Pharmaceuticals, Inc. (NASDAQ: ORMP) was established in 2006, and has developed a unique proprietary platform technology that allows for the oral delivery of drugs presently administered only via injection. From the company’s inception, Oramed…

  • Opexa Therapeutics (OPXA) Presents at Rodman & Renshaw Conference

    Opexa Therapeutics, Inc. (NASDAQ: OPXA) is a biotechnology company developing personalized immunotherapies with the potential to treat major illnesses, including multiple sclerosis (MS) as well as other autoimmune diseases, such as neuromyelitisoptica (NMO). These therapies…

  • Oncothyreon (ONTY) Presents at Rodman & Renshaw Conference

    Oncothyreon, Inc. (NASDAQ: ONTY) is a biotechnology company dedicated to the development of oncology products that can improve the lives and outcomes of cancer patients. Recognizing that cancer is a complex disease involving changes to…

  • OncoSec Medical (ONCS) Presents at Rodman & Renshaw Conference

    Established in 2011, OncoSec Medical Incorporated (NASDAQ: ONCS) is a San Diego-based biotechnology company pioneering new technologies to stimulate the body’s immune system to target and attack cancer. Through its proprietary technology, the company means…

  • Onconova Therapeutics (ONTX) Presents at Rodman & Renshaw Conference

    Onconova Therapeutics, Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created an extensive library of…

  • Oculus Innovative Sciences (OCLS) Presents at Rodman & Renshaw Conference

    Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) has designed a humanitarian program to respond to unexpected disasters—floods, earthquakes, tsunamis, hurricanes, epidemics and even man-made calamities—by providing product (such as food or medical assistance) to these victims.…

  • Ocera Therapeutics (OCRX) Presents at Rodman & Renshaw Conference

    Ocera Therapeutics, Inc. (NASDAQ: OCRX) is a clinical stage biopharmaceutical companyfocused on the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease. Ocera’s lead program, OCR-002 (ornithine phenylacetate) is an…

  • Ocean Power Technologies (OPTT) Presents at Rodman & Renshaw Conference

    Ocean Power Technologies, Inc. (NASDAQ: OPTT) is a pioneer in renewable wave-energy technology that converts ocean wave energy into electricity. OPT’s proprietary PowerBuoy technology is based on a modular design and has undergone periodic ocean…

  • ENGlobal Corp. (ENG) Bolsters Management Team, Prepares for Market Growth

    Through its engineering and construction group, ENGlobal Corp. (NASDAQ: ENG) delivers innovative, cost-effective automation and specialty construction projects for customers around the world. Consistently included on Engineering News Record magazine’s annual list of the top…

  • Novatel Wireless (NVTL) Presents at Rodman & Renshaw Conference

    Novatel Wireless, Inc. (NASDAQ: NVTL) delivers intelligent wireless solutions that simplify the Internet of Things (IoT). The company has invented and reinvented ways in which the world stays connected and accesses information. With multiple first-to-market…